Mind the gap: A national audit of radiotherapy prescription conformance and traceability

Journal of Radiotherapy in Practice

Volumn 3, Issue 3, 2003, Pages 139-146

  Smith, A ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

local tumour control audit; non conformity; prescriptions; Radiotherapy

Indexed keywords

EID: 85008545728     PISSN: 14603969     EISSN: 14671131     Source Type: Journal    
DOI: 10.1017/S1460396903000141     Document Type: Article

References (21)

1. Royal College of Radiologists. Board of Faculty of Clinical Oncologist. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy. London: Royal College of Radiologists, 1996.
2. Porter H. Management of interruptions to radiotherapy treatments. Technical Considerations. Beatson Oncology Centre, Glasgow, 1995.
3. Hendry JH, Bentzen SM, Dale RG, et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol 1996; 8(5).
4. Milecki P, Kruk-Zagajewska A, Szmeja Z, Cerkaska-Gluszak B. The influence of the duration of a break in a course of post-operative radiotherapy on the results of treatment with total laryngectomy due to cancer. Otolaryngologia Polska 1997; 51: 37-46.
5. Hoffstetter S, Marchal C, Peiffert D, Lupersi E, Lapwgre M, Pernot M, Bey P. Treatment duration as a prognostic factor for local control and survival in epidermoid carcinoma of the tonsillar region treated by combined external beam irradiation and brachytherapy. Radiother Oncol 1997; 45: 141-148.
6. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;40: 319-329.
7. Slevin NJ, Hendry JH, Roberts SA, Agren-Cronqvist A., The effects of increasing treatment time beyond three weeks on control of T2-T3 laryngeal cancers using radiotherapy. Radiother Oncol 1992; 24: 215-220.
8. Barton MB, Keane TJ, Galla T, Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy for laryngeal cancer. Radiother Oncol 1992; 23: 137-143.
9. Overgaard M, Hjelm-Hansen M, Vendelbo JL, Anderson AP. Comparison of convensional split-course radiotherapy as a primary treatment in cancer of the larynx. Acta Oncologia 1998;27: 147-161.
10. Royal College of Radiologists. Board of Faculty of Clinical Oncologist. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy. Second edition. London: Royal College of Radiologists, 2002.
11. Chen M, Jiang G, Fu X, et al. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer 2000; 28: 11-19.
12. Cox J. P., Pajak, T. F., Asbell S. Interruptions of high-dose radiation therapy decrease long-term survival of favourable patients withunresectable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1993; 27: 493-498.
13. Fowler JF, Chappell R. Non small cell lung tumours repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 2000; 46: 516-517.
14. Kal HB, El Sharouni SY, Wijrdeman HK. Radiotherapy for oesophageal cancer. Ann Oncology 1999; 10: 359-363.
15. Sykes AJ, Burt PA, Slevin NJ, Stout R, Marrs JE. Radical radiotherapy for carcinoma of the oesophagus. Radiother Oncol 1998; 48: 15-21.
16. Nishimura Y, Ono K, Tsutsui K, et al. Therapy, treated with radiotherapy: impact of total treatment time Co-ordinator. Helen Forbes. Clatterbridge NHS Trust, and fractionation. Int J Radiat Oncol Biol Phys 1994; 30: 2000.
17. Powell ME, Hoskin PJ, Saunders MI, Dische S. Royal College of Radiologists The role of biological effective dose (BED) in Clinical Continuous hyperfractionnated accelerated radiotherapy Oncology. 1997; 38: 133-138.
18. Department of Health. The NHS Cancer Plan. A plan for investment. A plan for reform. London, 2000.
19. Cottier B. Audit of radiographer staffing levels. Therapy Co-ordinator. Helen Forbes. Clatterbridge NHS Trust 2000.
20. Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DAL. The role of biological effective dose (BED) in Clinical Oncology. The Royal College of Radiologists 2001; 13: 71-81.
21. Bury T, Mead J. Evidence based healthcare. A practical guide for therapists. Oxford: Butterworth Heinemann, 1998.